secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANGAMO THERAPEUTICS, INC (SGMO)
CIK:        0001001233
Form:       8-K
Filed at:   2025-09-30T23:59:59+00:00
Accession:  0001001233-25-000013
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sangamo CFO Duraibabu resigns effective Oct 1, stays part-time; Jain new principal accounting officer
--------------------------------------------------------------------------------

- CFO Duraibabu resigns effective Oct 1, 2025; transitions to part-time principal financial officer role.
- Nikunj Jain, VP Finance & Corporate Controller since 2021, appointed principal accounting officer.
- Jain's agreement: annual base salary $347,548; target annual cash bonus 30% of base; eligible for equity awards.
- Duraibabu's part-time agreement: base salary $145,188; $160,000 retention bonus payable Jan 31, 2026.
- Duraibabu severance limited to change of control; no other severance under plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001233/000100123325000013/0001001233-25-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001233/000100123325000013/sgmo-20250924.htm
  HTML page:      https://secwatch.observer/filing/0001001233-25-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer